Cyclin D1 and MYEOV gene expression levels in lymphoma and carcinoma cell lines
. | . | QRT-PCR . | . | . | |
|---|---|---|---|---|---|
| Cell line . | Origin . | Cyclin D1 . | MYEOV . | 11q13 status . | |
| KMM1 | Multiple myeloma | Absent | 0.05 | ND | |
| OPM2 | Multiple myeloma | Absent | 0.05 | Not amplified | |
| KMS5 | Multiple myeloma | 0.07 | 0.42 | ND | |
| KMS11 | Multiple myeloma | 0.2 | 2.09 | Not amplified | |
| KMS12 | Multiple myeloma | 29 | 6.05 | t(11;14)(q13;q32) | |
| KMS18 | Multiple myeloma | Absent | 8.33 | Not amplified | |
| U266 | Multiple myeloma | 4.2 | 0.2 | Insertion 11q, disomy | |
| Ki-JK | Anaplastic large cell lymphoma | Absent | 0.59 | ND | |
| NCEB | Mantle cell lymphoma | 28.4 | 21.36 | t(11;14)(q13;q32) | |
| Granta 519 | Mantle cell lymphoma | 79 | 0.3 | t(11;14)(q13;q32) | |
| SUDHL-4 | DLCL | Absent | 0.06 | ND | |
| SUDHL-10 | DLCL | Absent | 2.84 | ND | |
| HT29 | Gastric carcinoma | 8.8 | 36.18 | Amplified | |
| A431 | Squamous carcinoma | 34.6 | 275 | Amplified | |
| MDA-MB231 | Breast carcinoma | 7.73 | 27.5 | Amplified | |
| MDA-MB468 | Breast carcinoma | 10.15 | 21.5 | Amplified | |
. | . | QRT-PCR . | . | . | |
|---|---|---|---|---|---|
| Cell line . | Origin . | Cyclin D1 . | MYEOV . | 11q13 status . | |
| KMM1 | Multiple myeloma | Absent | 0.05 | ND | |
| OPM2 | Multiple myeloma | Absent | 0.05 | Not amplified | |
| KMS5 | Multiple myeloma | 0.07 | 0.42 | ND | |
| KMS11 | Multiple myeloma | 0.2 | 2.09 | Not amplified | |
| KMS12 | Multiple myeloma | 29 | 6.05 | t(11;14)(q13;q32) | |
| KMS18 | Multiple myeloma | Absent | 8.33 | Not amplified | |
| U266 | Multiple myeloma | 4.2 | 0.2 | Insertion 11q, disomy | |
| Ki-JK | Anaplastic large cell lymphoma | Absent | 0.59 | ND | |
| NCEB | Mantle cell lymphoma | 28.4 | 21.36 | t(11;14)(q13;q32) | |
| Granta 519 | Mantle cell lymphoma | 79 | 0.3 | t(11;14)(q13;q32) | |
| SUDHL-4 | DLCL | Absent | 0.06 | ND | |
| SUDHL-10 | DLCL | Absent | 2.84 | ND | |
| HT29 | Gastric carcinoma | 8.8 | 36.18 | Amplified | |
| A431 | Squamous carcinoma | 34.6 | 275 | Amplified | |
| MDA-MB231 | Breast carcinoma | 7.73 | 27.5 | Amplified | |
| MDA-MB468 | Breast carcinoma | 10.15 | 21.5 | Amplified | |
ND indicates not done; and DLCL, diffuse large cell lymphoma.